EPA Triggers Emerging Viral Pathogens Policy for Ebola Virus

Due to the ongoing Ebola outbreak in Uganda, the United States EPA has engaged its Emerging viral Pathogens Policy (EVP). The current outbreak of Ebola Virus Disease is caused by infection with Sudan ebolavirus. The first confirmed case was identified in a 25-year-old male in the Mubende District of Uganda on September 19th; though it [...]

Canada Issued Emerging Viral Pathogens Policy for Monkeypox Virus

On July 23rd, 2022, the World Health Organization (WHO) declared the recent outbreak of Monkeypox virus “a public health emergency of international concern”.(1) This announcement has come following the continued worldwide spread of Monkeypox from 92 cases in 12 member countries reported in May to over 16,000 confirmed cases and 5 deaths in 75 member [...]

2022-10-19T19:40:51+00:00EPA, State|

The Path to Making Off-Label Disinfection Claims Against SARS-CoV-2 on EPA-Registered Products

Upon the outbreak of Coronavirus Disease 2019 (COVID-19), consumers were instructed by the Centers for Disease Control and Prevention (CDC) to protect themselves and their families by washing their hands with soap and water for at least 20 seconds or utilizing a hand sanitizer containing at least 60% alcohol when handwashing is not available.  CDC [...]

Frequently Asked Questions: COVID-19 Regulatory Pathways

In response to the COVID-19 pandemic, caused by a novel coronavirus SARS-CoV-2, the US EPA has announced certain streamlined processes for some disinfectant products. It is important to understand whether your product qualifies for any of these pathways, and what the associated requirements are. New Registrations  Does a new disinfectant or antimicrobial product qualify for [...]